This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Beijing Institute for Cancer Research. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Zhiqian Zhang: Innovator in Cancer Research
Introduction
Zhiqian Zhang is a prominent inventor based in Beijing, China. He has made significant contributions to the field of cancer research, particularly through his innovative work on antibodies.
Latest Patents
Zhiqian Zhang holds a patent for an "Antibody and binding fragment recognizing CACNA2D1 and use thereof." This patent discloses a method for searching, identifying, or validating a marker CACNA2D1 of tumor-initiating cells. The method involves immunizing an animal using HEP-12 cells originating from a recurrent tumor that is rich in originating cells. Additionally, the patent describes a monoclonal antibody that specifically recognizes CACNA2D1 or antigen-binding fragments thereof, along with its use for treating or preventing tumors or diseases related to CACNA2D1. He has 1 patent to his name.
Career Highlights
Zhiqian Zhang is affiliated with the Beijing Institute for Cancer Research, where he continues to advance his research in oncology. His work has the potential to impact the treatment and prevention of various cancers.
Collaborations
Zhiqian collaborates with notable colleagues in his field, including Wei Zhao and Limin Wang. Their combined expertise contributes to the innovative research being conducted at the institute.
Conclusion
Zhiqian Zhang is a key figure in cancer research, with a focus on innovative antibody development. His contributions are paving the way for new treatments and understanding of tumor biology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile